| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BHG712 | GDSC1000 | pan-cancer | AAC | 0.049 | 0.1 |
| mRNA | BRD-K71935468 | CTRPv2 | pan-cancer | AAC | -0.063 | 0.1 |
| mRNA | IPR-456 | CTRPv2 | pan-cancer | AAC | -0.063 | 0.1 |
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | -0.063 | 0.1 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | 0.46 | 0.1 |
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | 0.054 | 0.1 |
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | 0.05 | 0.1 |
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | 0.063 | 0.1 |
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | -0.06 | 0.1 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | 0.053 | 0.1 |